How has Stryker's Orthopaedics segment grown since 2022?

Stryker's Orthopaedics segment has shown volatile growth since 2022, with significant fluctuations in net income and revenue. Here's a detailed analysis: 1. **Net Income Growth**: The net income for the Orthopaedics segment has experienced a substantial increase from $299 million in 2022 Q1 to $2.99 billion by 2024 Q4. The growth rate has been impressive, with year-over-year increases of 6.95% on average over the past year. |code|Ticker|Name|Date|Net Income (FY)|market_code| |---|---|---|---|---|---| |SYK|SYK.N|Stryker|2022|2.358E9|169| |SYK|SYK.N|Stryker|2023|3.165E9|169| |SYK|SYK.N|Stryker|2024|2.993E9|169| 2. **Revenue Growth**: The total revenue for the segment has also grown steadily, rising from $22.6 billion in 2024 Q4 to $26 billion by 2025 Q4, with a year-over-year growth rate of 10.68%. 3. **Yearly Variations**: There have been variations in net income and revenue within the year, with a notable decline of 15.2% in net income and 2.5% in revenue in 2023 Q3. However, the segment recovered sharply, with a 103.02% increase in net income and 11.79% increase in revenue by 2024 Q4. 4. **Stability**: The segment's performance has shown a degree of stability, with a consistent increase in net income and revenue over the past year, despite some fluctuations. The average growth rate for net income has been around 20%, indicating a strong and healthy business segment. In conclusion, Stryker's Orthopaedics segment has demonstrated robust growth since 2022, with significant increases in both net income and revenue. While there have been some fluctuations, the overall trend has been positive, with the segment showing resilience and stability in its financial performance.